Schoepf 2016 Abstract Mito Xmas Meeting Innsbruck: Difference between revisions
Beno Marija (talk | contribs) (Created page with "{{Abstract |title= |authors= |year=2016 |event=Mito Xmas Meeting 2016 Innsbruck AT |abstract= }} {{Labeling }} == Affiliations == :::: ::::#") Β |
Beno Marija (talk | contribs) No edit summary |
||
Line 1: | Line 1: | ||
{{Abstract | {{Abstract | ||
|title= | |title=Mitochondrial Function in Primary Prostate Cancer. | ||
|authors= | Β | ||
|authors=SchΓΆpf B, Weissensteiner H, Charoentong P, SchΓ€fer G, Bukur V, Fendt L, Trajanoski Z, Kronenberg F, Gnaiger E & Klocker H | |||
|year=2016 | |year=2016 | ||
|event=Mito Xmas Meeting 2016 Innsbruck AT | |event=Mito Xmas Meeting 2016 Innsbruck AT | ||
|abstract= | |abstract=Reprogramming of energy metabolism is a hallmark of cancer. Mutations in the mitochondrial DNA (mtDNA) might contribute to cancer development and progression. We analyzed mitochondrial respiration of fresh malignant and non-malignant prostate tissue samples obtained from 50 prostate cancer patients via High-Resolution Respirometry (HRR), determined mtDNA copy numbers by duplex qPCR, sequenced the whole mtDNAs using Next-Generation Sequencing (NGS) and analyzed expression of mitochondria-related genes in a subset of 16 cases by RNA-sequencing. HRR uncovered a shift of respiratory activity from mitochondrial complex I to complex II accompanied by a substrate shift toward higher respiratory activity elicited especially by succinate and pyruvate. The mutation load was significantly higher in tumor tissue compared to the non-malignant counterpart. Heteroplasmy levels of potentially deleterious mutations in mtDNA genes correlated significantly with reduced complex I respiration capacity. RNA-seq revealed a signature of differentially expressed metabolic enzymes in tumors exhibiting a severe compared to a mild complex CI mt-phenotype. The gene signature corresponded to observed altered substrates effects on respiration, e.g. increased pyruvate and citrate and decreased glutamate oxidation. | ||
Β | |||
Β | |||
|mipnetlab=AT Innsbruck MitoFit, AT Innsbruck SBI | |||
}} | }} | ||
{{Labeling | {{Labeling | ||
|event=Poster | |||
}} | }} | ||
== Affiliations == | == Affiliations == | ||
:::: Β | :::: SchΓΆpf B(1), Weissensteiner H(1), Charoentong P(2), SchΓ€fer G(3,4), Bukur V(5), Fendt L(1), Trajanoski Z(2), Kronenberg F(1), Gnaiger E(6) & Klocker H(3) | ||
::::# | ::::# Div Genetic Epidemiology, Dept Medical Genetics, Molecular Clinical Pharmacology | ||
::::# Div Bioinformatics, Biocenter | |||
::::# Div Experimental Urology, Dept Urology | |||
::::# Dept Pathology | |||
::::# TRON gGmbH-Translational Oncology, Johannes-Gutenberg-University Medical Center, Mainz, Germany | |||
::::# Dept General Transplant Surgery, D. Swarovski Research Laboratory, Medical Univ Innsbruck, Austria. |
Revision as of 15:59, 7 December 2016
Mitochondrial Function in Primary Prostate Cancer. |
Link:
SchΓΆpf B, Weissensteiner H, Charoentong P, SchΓ€fer G, Bukur V, Fendt L, Trajanoski Z, Kronenberg F, Gnaiger E & Klocker H (2016)
Event: Mito Xmas Meeting 2016 Innsbruck AT
Reprogramming of energy metabolism is a hallmark of cancer. Mutations in the mitochondrial DNA (mtDNA) might contribute to cancer development and progression. We analyzed mitochondrial respiration of fresh malignant and non-malignant prostate tissue samples obtained from 50 prostate cancer patients via High-Resolution Respirometry (HRR), determined mtDNA copy numbers by duplex qPCR, sequenced the whole mtDNAs using Next-Generation Sequencing (NGS) and analyzed expression of mitochondria-related genes in a subset of 16 cases by RNA-sequencing. HRR uncovered a shift of respiratory activity from mitochondrial complex I to complex II accompanied by a substrate shift toward higher respiratory activity elicited especially by succinate and pyruvate. The mutation load was significantly higher in tumor tissue compared to the non-malignant counterpart. Heteroplasmy levels of potentially deleterious mutations in mtDNA genes correlated significantly with reduced complex I respiration capacity. RNA-seq revealed a signature of differentially expressed metabolic enzymes in tumors exhibiting a severe compared to a mild complex CI mt-phenotype. The gene signature corresponded to observed altered substrates effects on respiration, e.g. increased pyruvate and citrate and decreased glutamate oxidation.
β’ O2k-Network Lab: AT Innsbruck MitoFit, AT Innsbruck SBI
Labels:
Event: Poster
Affiliations
- SchΓΆpf B(1), Weissensteiner H(1), Charoentong P(2), SchΓ€fer G(3,4), Bukur V(5), Fendt L(1), Trajanoski Z(2), Kronenberg F(1), Gnaiger E(6) & Klocker H(3)
- Div Genetic Epidemiology, Dept Medical Genetics, Molecular Clinical Pharmacology
- Div Bioinformatics, Biocenter
- Div Experimental Urology, Dept Urology
- Dept Pathology
- TRON gGmbH-Translational Oncology, Johannes-Gutenberg-University Medical Center, Mainz, Germany
- Dept General Transplant Surgery, D. Swarovski Research Laboratory, Medical Univ Innsbruck, Austria.